Found: 7
Select item for more details and to access through your institution.
Complete genome sequence and the expression pattern of plasmids of the model ethanologen <italic>Zymomonas mobilis</italic> ZM4 and its xylose-utilizing derivatives 8b and 2032.
- Published in:
- Biotechnology for Biofuels, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13068-018-1116-x
- By:
- Publication type:
- Article
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo.
- Published in:
- Journal of Bone & Mineral Research, 2011, v. 26, n. 3, p. 630, doi. 10.1002/jbmr.244
- By:
- Publication type:
- Article
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
- Published in:
- International Journal of Oncology, 2017, v. 50, n. 4, p. 1191, doi. 10.3892/ijo.2017.3883
- By:
- Publication type:
- Article
Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 2, p. 532, doi. 10.3892/ijo.2014.2468
- By:
- Publication type:
- Article
Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human Osteoblasts.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 9, p. 2164, doi. 10.1002/cam4.1115
- By:
- Publication type:
- Article
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 3, p. 534, doi. 10.1002/cam4.599
- By:
- Publication type:
- Article